億帆醫藥(002019.SZ)間接持Bioton 31.65%的股權
格隆匯10月31日丨億帆醫藥(002019.SZ)披露擬通過現金支付方式分別收購Perfect Trend Ventures Ltd100%股權及Dongren Singapore Pte Ltd100%股權間接收購Bioton S.A. (“佰通公司”)31.65%股權的進展,近日,根據新加坡東人及Perfect Trend公司註冊地相關法律法規,公司完成了上述股權變更登記手續,取得了Perfect Trend公司股東登記證書及新加坡東人股東登記證明文件。
至此,公司通過持有新加坡東人、Perfect Trend公司100%股權間接持有佰通公司31.65%的股權所涉股權變更登記工作已全部辦理完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.